Statement Of Cash Flows [Abstract]

European Medical Solutions - Filing #3149844

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
5 584 EUR
5 578 EUR
5 584 EUR
6,000 EUR
241,000 EUR
241,000 EUR
241,000 EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in inventories
1 488 EUR
164,000 EUR
Adjustments for decrease (increase) in trade accounts receivable
43,000 EUR
126,000 EUR
Adjustments for increase (decrease) in trade accounts payable
1 763 EUR
248,000 EUR
Other adjustments for non-cash items
2 982 EUR
Adjustments for losses (gains) on disposal of non-current assets
36,000 EUR
117,000 EUR
Cash flows from (used in) operating activities
2 326 EUR
348,000 EUR
Cash flows from (used in) investing activities [abstract]
Proceeds from government grants, classified as investing activities
531,000 EUR
Cash flows from (used in) investing activities
992,000 EUR
1 343 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from borrowings, classified as financing activities
3 000 EUR
3 484 EUR
Repayments of borrowings, classified as financing activities
2 650 EUR
960,000 EUR
Proceeds from government grants, classified as financing activities
122,000 EUR
Dividends paid, classified as financing activities
521,000 EUR
Cash flows from (used in) financing activities
471,000 EUR
2 003 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
1,000 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
1 805 EUR
1 008 EUR
Cash and cash equivalents
4 232 EUR
2 427 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.